CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease ; volume:17 ; number:1 ; day:28 ; month:6 ; year:2022 ; pages:1-21 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (28.6.2022), 1-21, 12.2022

Creator: Puntambekar, Shweta S.
Moutinho, Miguel
Lin, Peter Bor-Chian
Jadhav, Vaishnavi
Tumbleson-Brink, Danika
Balaji, Ananya
Benito, Martin Alvarado
Xu, Guixiang
Oblak, Adrian
Lasagna-Reeves, Cristian A.
Landreth, Gary E.
Lamb, Bruce T.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13024-022-00545-9

URN: urn:nbn:de:101:1-2022082008262302176213

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Puntambekar, Shweta S.
Moutinho, Miguel
Lin, Peter Bor-Chian
Jadhav, Vaishnavi
Tumbleson-Brink, Danika
Balaji, Ananya
Benito, Martin Alvarado
Xu, Guixiang
Oblak, Adrian
Lasagna-Reeves, Cristian A.
Landreth, Gary E.
Lamb, Bruce T.
SpringerLink (Online service)

Other Objects (12)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease

Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline

Related objects

Reset password